Telix Pharmaceuticals Limited announced that the Board of Directors has granted Dr. Andreas Kluge, on his request, a leave of absence, for a period of approximately six months, from his current role as a Non-Executive Director of Telix, to enable him to deal with personal issues. The Telix Board anticipates that Dr. Kluge will return from his leave of absence on or around 29 September 2023.